Mark Baldry - 17 May 2024 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role: Chief Commercial Officer
Signature: /s/ Adam S. Mostafa, attorney-in-fact
Issuer symbol: XFOR
Transactions as of: 17 May 2024
Net transactions value: +$19,252
Form type: 4
Filing time: 14 Feb 2025, 16:08:25 UTC
Previous filing: 16 Feb 2024
Next filing: 08 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XFOR	Common Stock	Purchase	$14,654	+21,646	+23%	$0.6770	115,769	17 May 2024	Direct	F1
transaction	XFOR	Common Stock	Purchase	$4,598	+13,404	+12%	$0.3430	129,173	15 Nov 2024	Direct	F1
transaction	XFOR	Common Stock	Award	$0	+600,000	+464%	$0.000000	729,173	12 Feb 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person purchased shares of common stock through the Issuer's Amended and Restated 2017 Employee Stock Purchase Plan. Such purchases were inadvertently omitted from previous Form 4 filings and are now being reported.
F2	Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in three equal annual installments on February 12, 2026, February 12, 2027 and February 12, 2028, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.

Content

The Reporting Person purchased shares of common stock through the Issuer's Amended and Restated 2017 Employee Stock Purchase Plan. Such purchases were inadvertently omitted from previous Form 4 filings and are now being reported.

Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in three equal annual installments on February 12, 2026, February 12, 2027 and February 12, 2028, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.